Dienolone
A 19-nortestosterone-derived steroid with an added ring double bond, related to trenbolone and dienogest chemistry. Investigated briefly in mid-century animal work and later appearing as a prohormone target; virtually no human data.
01 Overview
Dienolone (17beta-hydroxyestra-4,9-dien-3-one is the closely related trienolone; dienolone denotes the estra-4,9-dien-3-one alcohol family) belongs to the 19-nor group and is chemically adjacent to trenbolone. It has been discussed as a designer/prohormone compound because precursors can convert toward this scaffold.
Human pharmacology is effectively absent. What is known derives from animal androgen bioassays and structural inference from the trenbolone family.
02 Mechanism
19-nortestosterone-class androgen-receptor agonist; the diene structure resists aromatisation and promotes strong AR-mediated anabolic signalling similar to trenbolone.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Anecdotal | 10–30 mg/day | Oral | No validated dosing; anecdote only. |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Anabolic activityAnimal assays and structural analogy to trenbolone suggest strong AR-mediated anabolism. | unquantified | Preclinical | |
| Non-estrogenic profileDiene structure is not a substrate for aromatase. | n/a | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| HPTA suppressionStrong suppression expected from a potent 19-nor androgen. | Severe | Expected | Preclinical | |
| Progestogenic effects19-nor steroids often carry progestin activity affecting libido and gynecomastia risk. | Moderate | Uncertain | Preclinical |